---
title: SEQENS vs Sterling Pharma Solutions
slug_a: seqens
slug_b: sterlingpharmasolutions
site: cdmo
review_signal_gate: closed
canonical_path: /compare/seqens/sterlingpharmasolutions
generated_by: BioBM Editorial AI
---

# SEQENS vs Sterling Pharma Solutions

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

SEQENS (seqens) is listed for cdmo. Global CDMO and specialty ingredients manufacturer with 16 production sites and 9 R&D centres offering custom development and GMP manufacturing of pharmaceutical APIs, intermediates, and specialty chemicals from preclinical to commercial scale.

Services: 8. Modalities: 1. Indications: 0. Locations: 15. Certifications: 9. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in locations (15).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

Sterling Pharma Solutions (sterlingpharmasolutions) is listed for cdmo. Small molecule CDMO offering comprehensive API development and manufacturing from discovery through commercial cGMP production, with specialized expertise in complex and hazardous chemistries and ADC bioconjugation.

Services: 15. Modalities: 3. Indications: 0. Locations: 14. Certifications: 18. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in certifications (18).

Review summary: Review summary withheld until site-level review gate opens.